Fig. 3From: Single-agent MOR208 salvage and maintenance therapy in a patient with refractory/relapsing diffuse large B-cell lymphoma: a case reportPeripheral blood lymphocyte immunophenotyping by flow cytometry. The percentage of B-lymphocyte and T-lymphocyte counts across treatment time. D, day of treatment with MOR208Back to article page